These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


694 related items for PubMed ID: 23777987

  • 21. Inhibition of cytochrome P450 enzymes and uridine 5'-diphospho-glucuronosyltransferases by vicagrel in human liver microsomes: A prediction of potential drug-drug interactions.
    Liu S, Wang Z, Chan E, Zhao Y, Kang J, Zhang X, Tian X.
    Chem Biol Interact; 2022 Jan 25; 352():109775. PubMed ID: 34910929
    [Abstract] [Full Text] [Related]

  • 22. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR.
    Drug Metab Dispos; 1999 Aug 25; 27(8):902-8. PubMed ID: 10421617
    [Abstract] [Full Text] [Related]

  • 23. Measurement of in vitro cytochrome P450 2B6 activity.
    Walsky RL, Obach RS.
    Curr Protoc Toxicol; 2009 Aug 25; Chapter 4():Unit4.27. PubMed ID: 23045012
    [Abstract] [Full Text] [Related]

  • 24. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes.
    Ramírez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ.
    Drug Metab Dispos; 2004 Sep 25; 32(9):930-6. PubMed ID: 15319333
    [Abstract] [Full Text] [Related]

  • 25. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH, Kwon SS, Jeong HU, Lee HS.
    Int J Mol Sci; 2017 May 01; 18(5):. PubMed ID: 28468305
    [Abstract] [Full Text] [Related]

  • 26. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
    He M, Jiang J, Qiu F, Liu S, Peng P, Gao C, Miao P.
    Food Chem Toxicol; 2013 Jul 01; 57():262-5. PubMed ID: 23583485
    [Abstract] [Full Text] [Related]

  • 27. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
    Guo Z, Raeissi S, White RB, Stevens JC.
    Drug Metab Dispos; 1997 Mar 01; 25(3):390-3. PubMed ID: 9172960
    [Abstract] [Full Text] [Related]

  • 28. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
    Sahi J, Black CB, Hamilton GA, Zheng X, Jolley S, Rose KA, Gilbert D, LeCluyse EL, Sinz MW.
    Drug Metab Dispos; 2003 Apr 01; 31(4):439-46. PubMed ID: 12642470
    [Abstract] [Full Text] [Related]

  • 29. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
    Casabar RC, Wallace AD, Hodgson E, Rose RL.
    Drug Metab Dispos; 2006 Oct 01; 34(10):1779-85. PubMed ID: 16855053
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.
    Desta Z, Soukhova NV, Flockhart DA.
    Antimicrob Agents Chemother; 2001 Feb 01; 45(2):382-92. PubMed ID: 11158730
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
    Mössner LD, Schmitz A, Theurillat R, Thormann W, Mevissen M.
    Am J Vet Res; 2011 Nov 01; 72(11):1505-13. PubMed ID: 22023129
    [Abstract] [Full Text] [Related]

  • 32. Characterization of inhibitory effects of perfluorooctane sulfonate on human hepatic cytochrome P450 isoenzymes: focusing on CYP2A6.
    Narimatsu S, Nakanishi R, Hanioka N, Saito K, Kataoka H.
    Chem Biol Interact; 2011 Nov 15; 194(2-3):120-6. PubMed ID: 21964418
    [Abstract] [Full Text] [Related]

  • 33. Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.
    Kang D, Geng T, Lian Y, Li Y, Ding G, Huang W, Ma S, Wang Z, Ma Z, Xiao W.
    Biomed Chromatogr; 2017 Jul 15; 31(7):. PubMed ID: 27891633
    [Abstract] [Full Text] [Related]

  • 34. Examination of purported probes of human CYP2B6.
    Ekins S, VandenBranden M, Ring BJ, Wrighton SA.
    Pharmacogenetics; 1997 Jun 15; 7(3):165-79. PubMed ID: 9241656
    [Abstract] [Full Text] [Related]

  • 35. In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.
    Taavitsainen P, Juvonen R, Pelkonen O.
    Drug Metab Dispos; 2001 Mar 15; 29(3):217-22. PubMed ID: 11181487
    [Abstract] [Full Text] [Related]

  • 36. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TK, Waxman DJ.
    Drug Metab Dispos; 1997 Aug 15; 25(8):985-93. PubMed ID: 9280407
    [Abstract] [Full Text] [Related]

  • 37. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail in vitro with emphasis on CYP2E1.
    Valicherla GR, Mishra A, Lenkalapelly S, Jillela B, Francis FM, Rajagopalan L, Srivastava P.
    Xenobiotica; 2019 Dec 15; 49(12):1396-1402. PubMed ID: 30747554
    [Abstract] [Full Text] [Related]

  • 38. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N, Oda Y, Hase I, Asada A.
    Br J Anaesth; 2001 Apr 15; 86(4):540-4. PubMed ID: 11573629
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole.
    Ueng YF, Hsieh CH, Don MJ.
    Food Chem Toxicol; 2005 May 15; 43(5):707-12. PubMed ID: 15778010
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.